Company intelligence / Profile preview

Diamedikum

Ludwigsburg, Baden-Württemberg, Germany

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Diamedikum is a specialized German healthcare provider and clinical research site focused on the comprehensive treatment of diabetes, metabolic disorders, and renal diseases. Operating as a Medizinisches Versorgungszentrum (MVZ), the company provides integrated outpatient care including diabetology, nutritional counseling, and podiatry. Diamedikum is a recognized center of excellence for advanced diabetes technologies, such as insulin pump therapy and continuous glucose monitoring (CGM) systems. Additionally, the organization actively participates in clinical trials for novel metabolic therapies, serving as a specialized site for Phase II through IV studies.

Therapeutic areas: EndocrinologyNephrologyMetabolic Disorders
Modalities: Small moleculeDeviceNon-pharmacological therapy
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Diamedikum.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diamedikum.

Explore the full profile